INTRODUCTION: Malignant pleural mesothelioma (MPM) is a rapidly fatal malignancy that is increasing in incidence. The caspase 8 inhibitor FLIP is an anti-apoptotic protein over-expressed in several cancer types including MPM. The histone deacetylase (HDAC) inhibitor Vorinostat (SAHA) is currently being evaluated in relapsed mesothelioma. We examined the roles of FLIP and caspase 8 in regulating SAHA-induced apoptosis in MPM. METHODS: The mechanism of SAHA-induced apoptosis was assessed in 7 MPM cell lines and in a multicellular spheroid model. SiRNA and overexpression approaches were used, and cell death was assessed by flow cytometry, Western blotting and clonogenic assays. RESULTS: RNAi-mediated FLIP silencing resulted in caspase 8-dependent apoptosis in MPM cell line models. SAHA potently down-regulated FLIP protein expression in all 7 MPM cell lines and in a multicellular spheroid model of MPM. In 6/7 MPM cell lines, SAHA treatment resulted in significant levels of apoptosis induction. Moreover, this apoptosis was caspase 8-dependent in all six sensitive cell lines. SAHA-induced apoptosis was also inhibited by stable FLIP overexpression. In contrast, down-regulation of HR23B, a candidate predictive biomarker for HDAC inhibitors, significantly inhibited SAHA-induced apoptosis in only 1/6 SAHA-sensitive MPM cell lines. Analysis of MPM patient samples demonstrated significant inter-patient variations in FLIP and caspase 8 expressions. In addition, SAHA enhanced cisplatin-induced apoptosis in a FLIP-dependent manner. CONCLUSIONS: These results indicate that FLIP is a major target for SAHA in MPM and identifies FLIP, caspase 8 and associated signalling molecules as candidate biomarkers for SAHA in this disease.
INTRODUCTION:Malignant pleural mesothelioma (MPM) is a rapidly fatal malignancy that is increasing in incidence. The caspase 8 inhibitor FLIP is an anti-apoptotic protein over-expressed in several cancer types including MPM. The histone deacetylase (HDAC) inhibitor Vorinostat (SAHA) is currently being evaluated in relapsed mesothelioma. We examined the roles of FLIP and caspase 8 in regulating SAHA-induced apoptosis in MPM. METHODS: The mechanism of SAHA-induced apoptosis was assessed in 7 MPM cell lines and in a multicellular spheroid model. SiRNA and overexpression approaches were used, and cell death was assessed by flow cytometry, Western blotting and clonogenic assays. RESULTS: RNAi-mediated FLIP silencing resulted in caspase 8-dependent apoptosis in MPM cell line models. SAHA potently down-regulated FLIP protein expression in all 7 MPM cell lines and in a multicellular spheroid model of MPM. In 6/7 MPM cell lines, SAHA treatment resulted in significant levels of apoptosis induction. Moreover, this apoptosis was caspase 8-dependent in all six sensitive cell lines. SAHA-induced apoptosis was also inhibited by stable FLIP overexpression. In contrast, down-regulation of HR23B, a candidate predictive biomarker for HDAC inhibitors, significantly inhibited SAHA-induced apoptosis in only 1/6 SAHA-sensitive MPM cell lines. Analysis of MPM patient samples demonstrated significant inter-patient variations in FLIP and caspase 8 expressions. In addition, SAHA enhanced cisplatin-induced apoptosis in a FLIP-dependent manner. CONCLUSIONS: These results indicate that FLIP is a major target for SAHA in MPM and identifies FLIP, caspase 8 and associated signalling molecules as candidate biomarkers for SAHA in this disease.
Authors: Vera Grinkevitch; Mark Wappett; Nyree Crawford; Daniel B Longley; Ultan McDermott; Simon S McDade; Stacey Price; Andrea Lees; Christopher McCann; Katherine McAllister; Jochen Prehn; Jamie Young; Jess Bateson; Lewis Gallagher; Magali Michaut; Vivek Iyer; Aikaterini Chatzipli; Syd Barthorpe; Daniel Ciznadija; Ido Sloma; Amy Wesa; David A Tice; Lodewyk Wessels; Mathew Garnett Journal: Mol Cancer Ther Date: 2022-04-01 Impact factor: 6.009
Authors: Daniela Schmid; Francois Fay; Donna M Small; Jakub Jaworski; Joel S Riley; Diana Tegazzini; Cathy Fenning; David S Jones; Patrick G Johnston; Daniel B Longley; Christopher J Scott Journal: Mol Ther Date: 2014-07-23 Impact factor: 11.454
Authors: Dario Barbone; Priscilla Cheung; Sailaja Battula; Sara Busacca; Steven G Gray; Daniel B Longley; Raphael Bueno; David J Sugarbaker; Dean A Fennell; V Courtney Broaddus Journal: PLoS One Date: 2012-12-26 Impact factor: 3.240
Authors: N Crawford; I Stasik; C Holohan; J Majkut; M McGrath; P G Johnston; G Chessari; G A Ward; D J Waugh; D A Fennell; D B Longley Journal: Cell Death Dis Date: 2013-07-18 Impact factor: 8.469